Assessing bone quality in breast cancer patients during mammograms
Bone Quality Assessment During Breast Cancer Treatment via Wrist Tomosynthesis in the Mammography Setting
This study is looking at how certain breast cancer treatments might impact bone health, and it’s designed for patients receiving these treatments, so they can get their bone health checked easily during their regular mammogram visits without any extra stress.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Henry Ford Health + Michigan State University Health Sciences NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project ID | NIH-11106808 on NIH RePORTER |
What this research studies
This research investigates how breast cancer treatments, particularly aromatase inhibitors, affect bone quality in patients. By using wrist tomosynthesis during routine mammography appointments, the study aims to identify bone loss that may not be detected by standard imaging methods. This approach allows for simultaneous monitoring of bone health without requiring additional appointments, which can be stressful for patients. The goal is to better understand the patterns of bone loss in different patient demographics and improve care for those at risk of fractures.
Who could benefit from this research
Good fit: Ideal candidates for this research are breast cancer patients undergoing treatment with aromatase inhibitors, particularly those who are postmenopausal.
Not a fit: Patients who are not receiving aromatase inhibitors or those with other types of breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved monitoring and management of bone health in breast cancer patients, reducing the risk of fractures.
How similar studies have performed: Other research has shown promise in using advanced imaging techniques to assess bone health, suggesting that this approach could be effective.
Where this research is happening
East Lansing, United States
- Henry Ford Health + Michigan State University Health Sciences — East Lansing, United States (Active)
Researchers
- Principal investigator: Yeni, Yener N — Henry Ford Health + Michigan State University Health Sciences
- Study coordinator: Yeni, Yener N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.